Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 12, 2021ScienceOpen Access

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants

View Full Paper
Ask AI
Bookmark
Share

Authors

APAmarendra PeguSOSarah O’ConnellSSStephen D. Schmidt

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Pegu et al. (2021) studied this question.

synapsesocial.com/papers/6a86f6483a1d8ec5fdd3d0eehttps://doi.org/10.1126/science.abj4176
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection2021 · 805 citations
  2. 2Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine2020 · 10,914 citations
  3. 3Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-192021 · 757 citations
  4. 4Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants2021 · 1,021 citations
  5. 5An mRNA Vaccine against SARS-CoV-2 — Preliminary Report2020 · 3,519 citations